Medicare Ban on Telehealth Abortion Drugs Without Strict In-Person Rules.
This bill introduces strict new rules for providers offering abortion-inducing drugs under the Medicare program. Any provider failing to meet requirements—including a physical examination, being present in the same room when the drug is taken, and scheduling an in-person follow-up—will be permanently banned from Medicare. This change effectively prohibits medication abortion via telehealth for Medicare beneficiaries, potentially limiting access to care.
Key points
Permanent exclusion from Medicare for providers who furnish abortion-inducing drugs without meeting specific in-person requirements.
The provider must be physically present in the same room when the patient takes the medication, eliminating telehealth options for this service.
Mandatory in-person follow-up visit required within 14 days after the drug is administered.
Expired
Citizen Poll